Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Acqua Implant,Ti,4.3X13: medical device reports filed with FDA

4,137 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

4,137
device reports naming the brand
0% of all MAUDE reports · about 577 a year
924
reports, 12 months to August 2026
876 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 4,137 reports that name the brand "GM Helix Acqua Implant,Ti,4.3X13" (endosseous dental implant), received between May 2019 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

924 reports arrived in the 12 months to August 2026, close to the 876 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (59.6%), loss of osseointegration (32.3%) and difficult to insert (1.2%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

093186Sep 2021: 42Oct 2021: 35Nov 2021: 37Dec 2021: 222022Jan 2022: 19Feb 2022: 35Mar 2022: 44Apr 2022: 75May 2022: 58Jun 2022: 40Jul 2022: 39Aug 2022: 44Sep 2022: 46Oct 2022: 46Nov 2022: 45Dec 2022: 732023Jan 2023: 81Feb 2023: 35Mar 2023: 59Apr 2023: 43May 2023: 30Jun 2023: 74Jul 2023: 55Aug 2023: 68Sep 2023: 58Oct 2023: 82Nov 2023: 45Dec 2023: 432024Jan 2024: 53Feb 2024: 49Mar 2024: 86Apr 2024: 78May 2024: 69Jun 2024: 99Jul 2024: 119Aug 2024: 62Sep 2024: 84Oct 2024: 72Nov 2024: 76Dec 2024: 852025Jan 2025: 72Feb 2025: 60Mar 2025: 39Apr 2025: 46May 2025: 0Jun 2025: 186Jul 2025: 81Aug 2025: 75Sep 2025: 66Oct 2025: 82Nov 2025: 74Dec 2025: 942026Jan 2026: 59Feb 2026: 70Mar 2026: 93Apr 2026: 47May 2026: 83Jun 2026: 87Jul 2026: 55Aug 2026: 114

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04669322019: 4920192020: 12720202021: 30920212022: 56420222023: 67320232024: 93220242025: 87520252026: 6082026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%4,137
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report64.5%2,667
Voluntary report0%0
User facility report0%0
Distributor report35.5%1,470
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,46659.6%62.8%
Loss of osseointegration1,33632.3%22.4%
Difficult to insertthe device was hard to insert511.2%0.4%
Fracturea broken bone220.5%1.6%
Separation failure110.3%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,28331%
Painpain, site not specified1,10026.6%
Inflammationinflammation3328%
Hemorrhage/blood loss/bleeding2556.2%
Swelling/ edema1904.6%
Hyperresponsive to stimuli1684.1%
Abscessa collection of pus1343.2%
Fistula872.1%
Tissue damage812%
Hypersensitivity/allergic reaction380.9%
Sinus perforation240.6%
Numbnessnumbness210.5%
Failure of implant40.1%
Swellingswelling30.1%
Inadequate osseointegration20%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Acqua Implant,Ti,4.3X13Product code DZEAll MAUDE reports
Reports4,1373,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer64.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Acqua Implant,Ti,4.3X13 reports

How many FDA reports name GM Helix Acqua Implant,Ti,4.3X13?

4,137 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 924 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (59.6%), loss of osseointegration (32.3%), difficult to insert (1.2%), fracture (0.5%) and separation failure (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (64.5%) and distributor reports (35.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Acqua Implant,Ti,4.3X13 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.